Table 1.

Study cohorts

Cohort (n)	Antiretroviral therapy
1 (8)	Efavirenz 600 mg q.d.
	Combivir® (lamivudine 150 mg + zidovudine 300 mg) b.i.d.
2 (8)	Efavirenz 600 mg q.d.
	Didanosine enteric coated 250 mg q.d.
	Tenofovir 300 mg q.d.
3 (8)	Nevirapine 200 mg b.i.d.
	Lamivudine 150 mg b.i.d.
	Tenofovir 300 mg q.d.
4 (5)	Kaletra® (lopinavir 400 mg + ritonavir 100 mg) b.i.d.
	Stavudine 40 mg b.i.d.
	Lamivudine 150 mg b.i.d.